LY-395153
LY-395153 is a chemical compound that has been studied for its potential effects on the central nervous system. It is primarily known as a selective agonist for the 5-HT2A receptor, a subtype of the serotonin receptor family. This compound has been of interest in pharmacological research due to its potential implications in the treatment of various neuropsychiatric disorders.
Chemical Structure and Properties[edit | edit source]
LY-395153 is a synthetic compound with a complex molecular structure. It is characterized by its affinity for the 5-HT2A receptor, which is a G protein-coupled receptor (GPCR) involved in various neurological processes. The chemical formula of LY-395153 is C_20H_25N_3O_2, and it has a molecular weight of 339.44 g/mol.
Pharmacodynamics[edit | edit source]
As a selective agonist of the 5-HT2A receptor, LY-395153 mimics the action of serotonin (5-HT) at this receptor site. The 5-HT2A receptor is widely distributed in the brain, particularly in areas such as the prefrontal cortex, hippocampus, and thalamus. Activation of this receptor is associated with various effects, including modulation of mood, perception, and cognition.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of LY-395153 involves its absorption, distribution, metabolism, and excretion. While specific data on LY-395153 may be limited, compounds of this class typically undergo hepatic metabolism and are excreted via the renal route. The bioavailability and half-life of LY-395153 would be critical factors in determining its potential therapeutic use.
Potential Therapeutic Applications[edit | edit source]
Research into LY-395153 has explored its potential use in treating conditions such as depression, anxiety disorders, and schizophrenia. The modulation of the 5-HT2A receptor is a common target in the treatment of these disorders, as it plays a role in regulating mood and emotional responses.
Research and Development[edit | edit source]
Studies on LY-395153 have primarily been conducted in preclinical settings. Animal models have been used to assess its efficacy and safety profile. The compound's ability to cross the blood-brain barrier and its selectivity for the 5-HT2A receptor are key factors in its development as a potential therapeutic agent.
Safety and Side Effects[edit | edit source]
As with any pharmacological agent, the safety profile of LY-395153 is of paramount importance. Potential side effects may include alterations in mood, perception, and cognition, which are consistent with its action on the 5-HT2A receptor. Further studies are required to fully elucidate its safety and tolerability in humans.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD